{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:38:54Z","timestamp":1792035534786,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SKY2023076"],"award-info":[{"award-number":["SKY2023076"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX22-0804"],"award-info":[{"award-number":["KYCX22-0804"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008256","name":"Nanjing Tech University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019\\u202FM652036"],"award-info":[{"award-number":["2019\\u202FM652036"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100910"],"award-info":[{"award-number":["32100910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bcp.2024.116444","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T12:14:43Z","timestamp":1721477683000},"page":"116444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Reg2 treatment is protective but the induced Reg2 autoantibody is destructive to the islets in NOD mice"],"prefix":"10.1016","volume":"227","author":[{"given":"Yi-Han","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Cheng","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Lu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Bing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10413","key":"10.1016\/j.bcp.2024.116444_b0005","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0140-6736(23)02179-7","article-title":"Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial","volume":"402","author":"Russell-Jones","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bcp.2024.116444_b0010","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.2337\/dc23-0671","article-title":"Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes","volume":"46","author":"Kutz","year":"2023","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.bcp.2024.116444_b0015","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/13543784.2022.2159806","article-title":"Recent developments in adjunct therapies for type 1 diabetes","volume":"31","author":"Timmons","year":"2022","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"2","key":"10.1016\/j.bcp.2024.116444_b0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/er.2018-00154","article-title":"Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions","volume":"40","author":"Rickels","year":"2019","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2024.116444_b0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/db06-0669","article-title":"RegII is a beta-cell protein and autoantigen in diabetes of NOD mice","volume":"56","author":"Gurr","year":"2007","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bcp.2024.116444_b0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.mce.2012.10.018","article-title":"Transcriptional activation of Reg2 and Reg3beta genes by glucocorticoids and interleukin-6 in pancreatic acinar and islet cells","volume":"365","author":"Luo","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116444_b0035","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1210\/en.2016-1551","article-title":"Reg2 Expression Is Required for Pancreatic Islet Compensation in Response to Aging and High-Fat Diet-Induced Obesity","volume":"158","author":"Li","year":"2017","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.bcp.2024.116444_b0040","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.4049\/jimmunol.1001596","article-title":"Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice","volume":"185","author":"Huszarik","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116444_b0045","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/dom.13644","article-title":"Dimorphic autoantigenic and protective effects of Reg2 peptide in the treatment of diabetic beta-cell loss","volume":"21","author":"Yu","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"11","key":"10.1016\/j.bcp.2024.116444_b0050","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.cmet.2022.09.024","article-title":"The gut peptide Reg3g links the small intestine microbiome to the regulation of energy balance, glucose levels, and gut function","volume":"34","author":"Shin","year":"2022","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bcp.2024.116444_b0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2337\/diabetes.51.2.339","article-title":"A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice","volume":"51","author":"Gurr","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116444_b0060","doi-asserted-by":"crossref","unstructured":"Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(43):17040-5.","DOI":"10.1073\/pnas.0705894104"},{"issue":"4","key":"10.1016\/j.bcp.2024.116444_b0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MED.0000000000000267","article-title":"Staging the progression to type 1 diabetes with prediagnostic markers","volume":"23","author":"Sosenko","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"11","key":"10.1016\/j.bcp.2024.116444_b0070","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2337\/dc23-0124","article-title":"Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes","volume":"46","author":"Tojjar","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.bcp.2024.116444_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112278","article-title":"Anti-tumor effect of single-chain antibody to Reg3a in colorectal cancer","volume":"396","author":"Du","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"13","key":"10.1016\/j.bcp.2024.116444_b0080","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1158\/0008-5472.CAN-18-2839","article-title":"Anti-CD24 Antibody-Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma","volume":"79","author":"Sun","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2024.116444_b0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mce.2015.12.002","article-title":"Recombinant Reg3alpha protein protects against experimental acute pancreatitis in mice","volume":"422","author":"Yu","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116444_b0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/14728222.2016.1123691","article-title":"Regenerating gene (REG) product and its potential clinical usage","volume":"20","author":"Takasawa","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bcp.2024.116444_b0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fcell.2019.00235","article-title":"Four Decades After the Discovery of Regenerating Islet-Derived (Reg) Proteins: Current Understanding and Challenges","volume":"7","author":"Chen","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116444_b0100","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1210\/en.2019-00073","article-title":"Reg3 Proteins as Gut Hormones?","volume":"160","author":"Shin","year":"2019","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2024.116444_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187153008783928361","article-title":"Possible roles of reg family proteins in pancreatic islet cell growth","volume":"8","author":"Liu","year":"2008","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"18","key":"10.1016\/j.bcp.2024.116444_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810584","article-title":"Recombinant Reg3alpha Prevents Islet beta-Cell Apoptosis and Promotes beta-Cell Regeneration","volume":"23","author":"Yu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116444_b0115","doi-asserted-by":"crossref","first-page":"35640","DOI":"10.1038\/srep35640","article-title":"Recombinant Reg3beta protein protects against streptozotocin-induced beta-cell damage and diabetes","volume":"6","author":"Luo","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2024.116444_b0120","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","article-title":"Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure","volume":"150","author":"Talchai","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2024.116444_b0125","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cmet.2020.03.002","article-title":"Beta Cell Dedifferentiation Induced by IRE1alpha Deletion Prevents Type 1 Diabetes","volume":"31","author":"Lee","year":"2020","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bcp.2024.116444_b0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/TP.0b013e3181933261","article-title":"Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy","volume":"87","author":"Tian","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.bcp.2024.116444_b0135","first-page":"2","article-title":"The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes","volume":"2","author":"Hill","year":"2013","journal-title":"Cell Regen (lond)."},{"issue":"4","key":"10.1016\/j.bcp.2024.116444_b0140","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbrc.2019.03.107","article-title":"Protective effects of HTD4010, a Reg3alpha\/PAP-derived peptide, in mouse model of acute pancreatitis via toll-like receptor 4 pathway","volume":"512","author":"Wu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116444_b0145","doi-asserted-by":"crossref","unstructured":"Lehotzky RE, Partch CL, Mukherjee S, Cash HL, Goldman WE, Gardner KH, et al. Molecular basis for peptidoglycan recognition by a bactericidal lectin. Proceedings of the National Academy of Sciences. 2010;107(17):7722-7.","DOI":"10.1073\/pnas.0909449107"},{"issue":"10","key":"10.1016\/j.bcp.2024.116444_b0150","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2024.116444_b0155","doi-asserted-by":"crossref","unstructured":"Tang S, Zhang M, Zeng S, Huang Y, Qin M, Nasri U, et al. Reversal of autoimmunity by mixed chimerism enables reactivation of \u03b2 cells and transdifferentiation of \u03b1 cells in diabetic NOD mice. Proceedings of the National Academy of Sciences. 2020;117(49):31219-30.","DOI":"10.1073\/pnas.2012389117"},{"issue":"11","key":"10.1016\/j.bcp.2024.116444_b0160","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.2337\/db13-0345","article-title":"Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial","volume":"62","author":"Herold","year":"2013","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.bcp.2024.116444_b0165","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI81722","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.bcp.2024.116444_b0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/dc13-0626","article-title":"B-Lymphocyte Depletion With Rituximab and \u03b2-Cell Function: Two-Year Results","volume":"37","author":"Pescovitz","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.bcp.2024.116444_b0175","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2337\/db19-0057","article-title":"Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data","volume":"68","author":"Haller","year":"2019","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.bcp.2024.116444_b0180","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2337\/dc09-0054","article-title":"Etanercept Treatment in Children With New-Onset Type 1 Diabetes","volume":"32","author":"Mastrandrea","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2024.116444_b0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2015.01.001","article-title":"Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients","volume":"58","author":"Rosenzwajg","year":"2015","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.bcp.2024.116444_b0190","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00125-020-05200-w","article-title":"Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I\/II randomised, double-blind, placebo-controlled, dose-finding study","volume":"63","author":"Rosenzwajg","year":"2020","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.bcp.2024.116444_b0195","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/dmrr.999","article-title":"Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP)","volume":"25","author":"Dungan","year":"2009","journal-title":"Diabetes Metab. Res. Rev."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:28:48Z","timestamp":1777411728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224004271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":39,"alternative-id":["S0006295224004271"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116444","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reg2 treatment is protective but the induced Reg2 autoantibody is destructive to the islets in NOD mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116444"}}